Eyenovia has enrolled the first patient in a phase 3 study of MicroPine for the treatment of progressive myopia, according to a press release.The multicenter, double-masked CHAPERONE study will evaluate MicroPine, a topical atropine micro-formulation d…
Kids with extra fingers on their hands usually have them removed soon after birth, but some get to keep them into adulthood. This condition, known as polydactyly, is usually looked upon as a disability that has to be studied and addressed. Researchers at the University of Freiburg in Germany, Imperial College London, and the Université [&hel (Read more...)
DUBLIN–(BUSINESS WIRE)–The “Global Vision Care Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. Global Vision Care Market: Size, Trends and Forecast (2019-2023) provides an in-depth analysis of the vision care market including a detailed description of market sizing and growth. The report provides an analysis of the global vision care market by value and by segments. The report also includes a detailed segment analysis of the vision ca
ReWalk Robotics, a company with offices in Marlborough, Massachusetts and Yokneam Ilit, Israel, won FDA approval and a CE mark for its ReStore Exo-Suit, clearing the device for sale in the United States and EU countries. The ReStore Exo-Suit had its beginnings at Harvard’s Wyss Institute for Biologically Inspired Engineering. It is made (Read more...)
LOS ANGELES–(BUSINESS WIRE)–Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
Excess nitric oxide (NO) in the body is involved in rheumatoid arthritis and other inflammatory diseases. Reducing the amount of NO may lead to a new therapeutic approach for a variety of conditions. Researchers at the Pohang University of Science & Technology in South Korea have developed an NO-scavenging nanogel and tested it in mice [&hellip (Read more...)